Verteporfin inhibits growth of human glioma in vitro without light activation
Abstract Verteporfin (VP), a light-activated drug used in photodynamic therapy for the treatment of choroidal neovascular membranes, has also been shown to be an effective inhibitor of malignant cells. Recently, studies have demonstrated that, even without photo-activation, VP may still inhibit cert...
Saved in:
Main Authors: | Ahmad Al-Moujahed, Katarzyna Brodowska, Tomasz P. Stryjewski, Nikolaos E. Efstathiou, Ioannis Vasilikos, Joanna Cichy, Joan W. Miller, Evangelos Gragoudas, Demetrios G. Vavvas |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/f2b0e6444b7e4b96bbf25cb0fb97f1fa |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utilizing targeted gene therapy with nanoparticles binding alpha v beta 3 for imaging and treating choroidal neovascularization.
by: Hani Salehi-Had, et al.
Published: (2011) -
Dramatic Reduction of Distant Pancreatic Metastases Using Local Light Activation of Verteporfin with Nab-Paclitaxel
by: Michael Pigula, et al.
Published: (2021) -
Profile of verteporfin and its potential for the treatment of central serous chorioretinopathy
by: Karim SP, et al.
Published: (2013) -
Atorvastatin Promotes Phagocytosis and Attenuates Pro-Inflammatory Response in Human Retinal Pigment Epithelial Cells
by: Bo Tian, et al.
Published: (2017) -
Local photoreceptor cell death differences in the murine model of retinal detachment
by: Daniel E. Maidana, et al.
Published: (2021)